JUL 29, 2019 7:57 AM PDT

Medications Used for Atrial fibrillation May Increase Falls

WRITTEN BY: Nouran Amin

Falls among older adults are a growing health concern that often lead to injury, hospitalization, and other severe complications. Older adults are even at a higher risk of falling with debilitating chronic conditions and being prescribed certain drugs.

For example, atrial fibrillation—a condition characterized by the rapid contraction in one region of the heart—is most common among adults over 65 and is one of the major contributors to falling and fainting.

Learn more about atrial fibrillation:

Treatments for atrial fibrillation often include beta-blockers, certain calcium channel blockers (diltiazem, verapamil), and digoxin. Others drugs may also include amiodarone, flecainide, and propafenone. Unfortunately, these treatments increase the risk of falling among older adults but the connection to how this happens has not been studied until now

In a publication in the Journal of the American Geriatrics Society, researchers used data generated from Danish health records of atrial fibrillation patients between 65 and 100 years who were prescribed treatments. The researchers then examined those patients who had hospital admissions for falls or fainting and who suffered fall-related injuries such as varying degrees of head injuries or a fractured thigh, elbow, forearm, wrist, shoulder or upper arm, pelvis, and skull.

Results showed that patients who took amiodarone were at a significant risk of falling whether on short-term or long-term treatment and the medication digoxin held a slight association with fall-related injuries. In addition, treatments taken within the first 90 days, particularly the first two weeks, contributed to an even higher risk of injury.

"Our findings add evidence that, for older patients with atrial fibrillation, treatment with amiodarone is associated with a higher risk of fall-related injuries and fainting," stated the researchers.

Overall, the findings conclude the critical importance of health care providers weighing the pros and cons of reporting atrial fibrillation treatments to patients and the potential risk it may cause regarding their safety and patient care.

Source: Health in Aging

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
FDA Approves Drugs Faster than Ever- But is That Good?
The Food and Drug Administration (FDA) is approving new drugs for patients on less and less evidence thanks to special programs that streamline their appro...
JAN 18, 2020
Drug Discovery & Development
JAN 18, 2020
Using Vitamins to Treat Pediatric Sepsis
New research indicates that is very much possible to treat pediatric septic shock in children with a combination of intravenous vitamin C and intravenous v...
FEB 08, 2020
Cancer
FEB 08, 2020
Magic mushrooms help cancer patients' depression
A follow-up to a study originally published in the Journal of Psychopharmacology in 2016 reports the long-term benefits of a one-time, single-dose tre...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
Healing Bone Fractures
Studies on rats revealed that two existing drugs can boost repair machinery by triggering the release of bone marrow stem cells. Findings were published in...
MAR 22, 2020
Cancer
MAR 22, 2020
What is "Shotgun ion mobility mass spectrometry sequencing"?
Research published recently in Nature Communications highlights a new method of mapping an essential family of polysaccharides called GAGs (glycosaminoglyc...
MAR 31, 2020
Cancer
MAR 31, 2020
Ovarian cancer metastasis and CPT1A
Research published in the journal Molecular Cancer Research from collaborators at the University of Colorado Cancer Center hits on new insight as...
Loading Comments...